Journal of Biological Chemistry · 2005 · 366 citations · 35 references
MedicineBiochemistryMolecular BiologyEnzymologyHemostasisInflammationCoagulation AbnormalitiesCoagulation CascadeCoagulation PhysiologyFibrin FormationPlatelet AggregationThrombin GenerationCoagulation InitiationCoagulation Protease ActivationFactor ViiaNatural Anticoagulant PathwaysProthrombin ActivationSerine Protease MechanismZymogen Activation In Coagulation
Proteases function at every level in host defense, from regulating vascular hemostasis and inflammation to mobilizing the “rapid responder” leukocytes of the immune system by regulating the activities of various chemoattractants. Recent studies implicate proteolysis in the activation of a ubiquitous plasma chemoattractant, chemerin, a ligand for the G-protein-coupled receptor CMKLR1 present on plasmacytoid dendritic cells and macrophages. To define the pathophysiologic triggers of chemerin activity, we evaluated the ability of serum- and inflammation-associated proteases to cleave chemerin and stimulate CMKLR1-mediated chemotaxis. We showed that serine proteases factor XIIa and plasmin of the coagulation and fibrinolytic cascades, elastase and cathepsin G released from activated neutrophil granules and mast cell tryptase are all potent activators of chemerin. Activation results from cleavage of the labile carboxyl terminus of the chemoattractant at any of several different sites. Activation of chemerin by the serine protease cascades that trigger rapid defenses in the body may direct CMKLR1-positive plasmacytoid dendritic cell and tissue macrophage recruitment to sterile sites of tissue damage, as well as trafficking to sites of infectious and allergic inflammation. Proteases function at every level in host defense, from regulating vascular hemostasis and inflammation to mobilizing the “rapid responder” leukocytes of the immune system by regulating the activities of various chemoattractants. Recent studies implicate proteolysis in the activation of a ubiquitous plasma chemoattractant, chemerin, a ligand for the G-protein-coupled receptor CMKLR1 present on plasmacytoid dendritic cells and macrophages. To define the pathophysiologic triggers of chemerin activity, we evaluated the ability of serum- and inflammation-associated proteases to cleave chemerin and stimulate CMKLR1-mediated chemotaxis. We showed that serine proteases factor XIIa and plasmin of the coagulation and fibrinolytic cascades, elastase and cathepsin G released from activated neutrophil granules and mast cell tryptase are all potent activators of chemerin. Activation results from cleavage of the labile carboxyl terminus of the chemoattractant at any of several different sites. Activation of chemerin by the serine protease cascades that trigger rapid defenses in the body may direct CMKLR1-positive plasmacytoid dendritic cell and tissue macrophage recruitment to sterile sites of tissue damage, as well as trafficking to sites of infectious and allergic inflammation. A network of serine proteases regulates the primary response to injury and infection in the host. Serine proteases of the coagulation and fibrinolytic cascades mediate the homeostatic response to blood vessel injury. Kallikrein and factor XIIa process kininogens to generate bradykinin, a potent vasodilator that triggers increased vascular permeability during inflammation. Serine proteases termed convertases release multiple pathogen-neutralizing components of activated complement. Serine protease cascades also regulate the recruitment of phagocytic and antigen-presenting cells to sites of inflammation and tissue damage. The complement cascade, for example, releases active components C5a and C3a, potent attractants for many leukocytes, including neutrophils and monocytes (1Fernandez H.N. Henson P.M. Otani A. Hugli T.E. J. Immunol. 1978; 120: 109-115PubMed Google Scholar, 2Falk W. Leonard E.J. Infect. Immun. 1980; 29: 953-959Crossref PubMed Google Scholar). Thus serine proteases are critical participants in rapid defense mechanisms in the body. We and others have recently identified chemerin as a potent chemoattractant for cells expressing the G-protein-linked receptor chemokine-like receptor 1 (CMKLR1), 5The abbreviations used are: CMKLR1, chemokine-like receptor 1; pDC, plasmacytoid dendritic cell; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; tPA, tissue-type plasminogen activator; uPA, urokinase-type plasminogen activator. 5The abbreviations used are: CMKLR1, chemokine-like receptor 1; pDC, plasmacytoid dendritic cell; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; tPA, tissue-type plasminogen activator; uPA, urokinase-type plasminogen activator. also known as ChemR23 or DEZ (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar, 4Meder W. Wendland M. Busmann A. Kutzleb C. Spodsberg N. John H. Richter R. Schleuder D. Meyer M. Forssmann W.G. FEBS Lett. 2003; 555: 495-499Crossref PubMed Scopus (154) Google Scholar, 5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar). CMKLR1 is expressed in vitro by monocyte-derived macrophages and dendritic cells (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar, 5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar, 6Samson M. Edinger A.L. Stordeur P. Rucker J. Verhasselt V. Sharron M. Govaerts C. Mollereau C. Vassart G. Doms R.W. Parmentier M. Eur. J. Immunol. 1998; 28: 1689-1700Crossref PubMed Scopus (194) Google Scholar) and in vivo by circulating plasmacytoid dendritic cells (pDCs) (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar) and tissue macrophages. 6B. A. Zabel, manuscript in preparation. 6B. A. Zabel, manuscript in preparation. pDCs are major producers of α-interferons and can differentiate into antigen-presenting cells capable of triggering T effector or suppressor responses (7Colonna M. Trinchieri G. Liu Y.J. Nat. Immunol. 2004; 5: 1219-1226Crossref PubMed Scopus (1329) Google Scholar). Tissue macrophages have a major role as phagocytes but, similar to pDCs, are also implicated in bridging innate and adaptive immune responses and in regulating immunity in sterile versus infectious tissue injury (8Stoy N. Pathobiology. 2001; 69: 179-211Crossref PubMed Scopus (30) Google Scholar). Importantly, chemerin is widely expressed and circulates in human plasma in an inactive state (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar). Active forms of chemerin have been isolated from human ascites fluid, hemofiltrate, and serum and are characterized by apparent proteolytic cleavage of carboxyl-terminal amino acids present in the relatively inactive full-length pro-chemoattractant (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar, 4Meder W. Wendland M. Busmann A. Kutzleb C. Spodsberg N. John H. Richter R. Schleuder D. Meyer M. Forssmann W.G. FEBS Lett. 2003; 555: 495-499Crossref PubMed Scopus (154) Google Scholar, 5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar). Here we have identified serine proteases as potent triggers of chemerin activation. Serum enzymes can activate recombinant chemerin, and this activity was blocked by selective serine protease inhibition. The clotting-associated serine proteases, factors XIIa and VIIa, and the fibrinolysis-associated serine proteases plasmin and plasminogen activators can all activate chemerin. Inflammatory cell-associated serine proteases, including neutrophil granule elastase and mast cell tryptase, are activators as well. Moreover, we found that several different cleavage sites, present in endogenous serum chemerin or generated during processing with specific enzymes, are sufficient for activation of this potent leukocyte attractant. These findings add chemerin to the list of innate immune mediators whose activity is critically regulated by serine protease cascades and implicate chemerin as an important link between these mechanisms of blood and tissue hemostasis and the recruitment of specialized CMKLR1-expressing “rapid responder” macrophages and dendritic cells. In Vitro Transwell Chemotaxis—CMKLR1/L1.2 transfectants were generated as previously described (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar). 5-μm pore Transwell inserts (Costar) were used for the migration assays. 100 μl of cells were added to the top well, and test samples were added to the bottom well in a 600-μl volume. The chemotaxis medium consisted of RPMI 1640 plus 10% fetal calf serum plus additives. Migration was assayed for 2 h at 37 °C, the inserts were removed, and the cells that had migrated through the filter to the lower chamber were counted by flow cytometry. ∼2.5 × 105 cells/well were used as input, and the number of cells counted in 30 s was defined as the migration output. The results are reported as % input migration or % maximal migration. Chemerin Expression and Purification Using Baculovirus—Chemerin with a carboxyl-terminal His6 tag was cloned into pACGP67 (BD Biosciences) and transfected into Sf-9 cells. The expressed protein has the sequence NH2-ADPELTEA... LPRSPHHHHHH-COOH, where the underlined residues are non-native. After viral amplification, chemerin was expressed by adding high titer virus to shaker flasks containing Hi-5 insect cells in Ex-cell 420 media (JRH Biosciences). After incubation for 2–3 days at 27.5 °C, the supernatant was harvested by centrifugation, filtered to 0.22 μm, and concentrated at 4 °C using a tangential flow concentrator (Filtron) with a 3-kDa cutoff filter. After a >100-fold buffer exchange into 50 mm HEPES, 0.3 m NaCl, pH 8.0, chemerin was purified by running the solution over nickel-nitrilotriacetic acid, SP-Sepharose (Amersham Biosciences) and C-18 reverse phase high pressure liquid chromatography columns (Vydac). The protein was lyophilized and checked for purity using electrospray mass spectrometry. Chemerin Expression and Purification from Escherichia coli—Chemerin with a carboxyl-terminal His6 tag (having the sequence NH2-MELTEA...LPRSPHHHHHH-COOH, where the underlined residues are non-native) was expressed in TAP302 cells for 4 h at 37 °C. The cell pellets were spun down and detergent-solubilized by successive rounds of homogenization and spinning in the presence of 0.25% sodium deoxycholate. The insoluble inclusion body pellet was solubilized in a denaturing buffer (6 m guanidine HCl, 0.1 m sodium phosphate, 10 mm Tris, pH 8.0) and run over a nickel-nitrilotriacetic acid column using a decrease in pH to elute. The FoldIt screen (Hampton Research) was used to test suitable refolding conditions, and a modified version of buffer 11 was chosen as the best choice (50 mm HEPES, 0.3 m NaCl, 0.44 mm KCl, 2.2 mm MgCl2, 2.2 mm CaCl2, 550 mm l-arginine, 0.055% polyethylene glycol 8000, 1 mm reduced l-glutathione, 0.1 mm oxidized l-glutathione, pH 8.0). Chemerin was refolded by rapidly diluting into the refolding buffer at a final protein concentration of 0.1–0.2 mg/ml. After stirring for a few hours at 4 °C, the protein was rapidly diluted 20-fold further into column buffer (50 mm HEPES, 0.3 m NaCl, pH 8.0) and filtered. The protein was concentrated and purified using the tangential flow concentrator and chromatography, as described in the previous paragraph for baculovirus expression. Serum—The Institutional Review Board at Stanford all human and was for all Serum was of by the over a of E. chemerin input migration was with an of serum or plasma for at 37 °C and in a chemotaxis with were from blood from by using (Amersham Biosciences). The high containing neutrophils and was with solution of in and for at were from the phase and to to blood cells. neutrophil were for h in RPMI 1640 media were and on protein as by a to the media samples containing of protein were for with recombinant chemerin. Serine Proteases and was with × m or × m for 1 h chemerin was medium was with 4 × m plus or 1 × m for 30 chemerin was of serine proteases were with chemerin for at 37 °C and in chemotaxis. In was by the on and diluting the samples into chemotaxis medium for The active forms of the and complement enzymes were used at on blood as × m 2.2 × m factor × m factor VIIa, × m factor × m factor × m factor × m × m plasmin of and × m factor × m factor × m and × m 2004; PubMed Scopus Google Scholar). and were used at on blood of 2.2 × m and × m 2004; PubMed Scopus Google Scholar). and urokinase-type plasminogen activators were used at × m and × isolated from was used at × cell tryptase isolated from human was used at × to × neutrophil elastase and cathepsin G were used at 1 × and and were used at 1 × m of the enzymes or activity in Transwell chemotaxis using and electrospray mass were by the Stanford and the of and the mass were used in a of was used to the mass of various chemerin and to chemerin Serum Serine Proteases is potent plasma in the chemotaxis of CMKLR1-positive cells (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google that activate proteases capable of plasma chemerin to an active To test this we serum of endogenous by over a the endogenous serum activity incubation of the serum with recombinant full-length the activity of the The triggering was as chemerin activity at 37 °C a serine protease the protease blocked chemerin activation by that serum serine proteases are for chemerin activation. the serine protease also activated chemerin, with a direct activity of serine proteases on the serine proteases of the and cascades activate chemerin full-length was to activity CMKLR1 and was for at 37 °C with the enzymes migration was was used at to blood plasminogen × as well as to the blood are for factor VIIa, factor and The used for and were reported for in vitro 2004; PubMed Google Scholar). chemerin activity, the of of with similar is with the in of maximal the responses for chemerin were from and a on the best response is Serine protease Chemerin activity migration m % % × × × 100 × XIIa × × × × G × × × in a a of the serum we recombinant chemerin with factors VIIa, and or plasmin for at 37 °C and assayed for blood plasminogen an blood and tissue serine protease that and to was a potent blood plasmin in also coagulation factors and XIIa were potent activators of chemerin the was reduced factors XIIa and were used at blood generated activated chemerin, similar to the ability of serum of the serine proteases of the coagulation showed activity in the blood The serine proteases and cleave plasminogen to generate these enzymes also activate chemerin the were plasma of and the concentration was similar to the level to cleave primary plasminogen J. Detheux M. Vassart G. Forssmann W.G. Parmentier M. J. Immunol. 2001; PubMed Scopus Google Scholar, S. PubMed Scopus Google Scholar, 2004; PubMed Google Scholar). plasminogen activators increased to activate plasminogen in the state V. J. PubMed Google Scholar, M. D. J. PubMed Google tPA, a of in plasminogen activation in the presence of Thus and may a role in chemerin activation in vivo concentrated on cell or To plasmin a active cleavage of chemerin, we recombinant chemerin with plasmin and evaluated the by with a of plasmin × over h at 37 °C generated a primary proteolytic with a 20-fold in with the that the recombinant chemerin a of a as this may for the level of activity to incubation with Using a specific to the full-length (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar) showed that full-length chemerin, purified from cleavage had Proteases G and are to sites of inflammation release an of enzymes and factors that regulate the including the recruitment of leukocytes S. J. Med. 2001; Google Scholar). To neutrophils release proteases that activate chemerin, we recombinant full-length chemerin with The media potent activity, the release of neutrophil granule had activity for CMKLR1 ability a serine protease blocked chemerin activation that serine proteases released neutrophil activate chemerin. The serine proteases elastase and cathepsin G are major components of primary granules of generated active chemerin of neutrophil elastase and cathepsin G by selective and chemerin activation activity, is for the of the active Serine Proteases of the proteases of the complement trigger complement components that as potent leukocyte we evaluated the chemerin activation ability of factors and and and blood the of the reported used for cleavage of complement factor cleavage of J. Immunol. Google cleavage of S. S. A. PubMed Scopus Google factor cleavage of factor D. M. A. S. A. PubMed Scopus Google and cleavage of the of J. P. P. P. J. Immunol. 2001; PubMed Scopus Google had a on chemerin a Chemerin cell granules and the the serine protease cell tryptase also circulates in the and serum tryptase are in × can in S. E. 2003; PubMed Scopus Google Scholar). of tryptase × activate chemerin, × as a potent the for Serum (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar, V. P. Vassart G. Communi D. Parmentier M. J. 2004; PubMed Scopus Google Scholar) that proteolytic cleavage in the carboxyl terminus of chemerin results in activation. To the of cleavage of serum chemerin, we isolated the active from serum as described previously (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar) and mass of identified of the protein In to with cleavage sites, a mass of to a amino acids from the carboxyl terminus of chemerin A and the carboxyl-terminal processing of serum chemerin and In mass of a from human serum a with a mass of of the of the cleavage is from defined previously by W. Wendland M. Busmann A. Kutzleb C. Spodsberg N. John H. Richter R. Schleuder D. Meyer M. Forssmann W.G. FEBS Lett. 2003; 555: 495-499Crossref PubMed Scopus (154) Google Scholar) from and (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar) from ascites has been recently reported by Busmann A. M. Wendland M. Kutzleb C. Forssmann W.G. John H. J. 2004; PubMed Scopus Google Scholar) as a present in cell Chemerin for and define the sites of chemerin cleavage by specific enzymes, we of the recombinant full-length to generate the active and used electrospray and mass to define the cleavage identified a plasmin carboxyl-terminal cleavage as is a serine protease cleavage as by carboxyl-terminal cleavage sites were activation with neutrophil with activity and for to of these is the as that of the active chemerin in in mast cell tryptase also generated several carboxyl-terminal cleavage including the serum The ubiquitous of is of the of tissue factor in sites. Tissue factor is the potent of the and a J. Google for the rapid and of in vascular chemerin may as a ubiquitous to tissue or into rapidly generated for specialized CMKLR1-positive cells. Serine proteases of the or cascades trigger cleavage of the carboxyl-terminal of the and to recruitment of CMKLR1-positive cells the active human chemerin have been all with different carboxyl-terminal We have in that serine proteases can generate the forms reported by (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar) in ascites or by in results that the cell-associated serine proteases, elastase and tryptase, can generate active the of cleavage of amino of the several cleavage generated by tryptase and elastase are active as CMKLR1 to The for of leukocyte by serine proteases during tissue responses is well by the for the many of plasmin in this a chemoattractant for monocytes M. PubMed Google Scholar). cleavage of complement the C3a, is a potent chemoattractant for and mast cells S. J. R. S. I. PubMed Google Scholar). proteolysis the J. PubMed Scopus Google as well as plasma chemoattractant, or 1; to T and monocytes J. Detheux M. Vassart G. Forssmann W.G. Parmentier M. J. Immunol. 2001; PubMed Scopus Google Scholar, P. Meyer M. M. J. M. A. M. R. A. M. M. Forssmann W.G. J. Exp. Med. PubMed Scopus Google Scholar). Chemerin a of and regulated by plasmin and the fibrinolytic the chemerin receptor CMKLR1 is a of a of leukocyte G-protein-coupled that chemoattractant for a number of activated or regulated The receptor for C3a, for example, is to CMKLR1, as is the receptor for the complement C5a P. A. Google blood protein that is activated and in rapid responses innate and adaptive of the receptor is expressed on neutrophils and as a chemoattractant receptor for human J. J. Exp. Med. PubMed Scopus Google is also generated by proteolytic processing from an inactive J. R. Eur. J. PubMed Scopus Google Scholar). A of this chemoattractant receptor to an for in the rapid host defense or response to injury. with the processing of regulated mediators of responses proteolytic enzymes, as the serum Immunol. 2004; PubMed Scopus Google Scholar) or the known as or is activated by or neutrophil elastase M. J. J. 2003; PubMed Scopus Google Scholar, N. P. Med. 2004; PubMed Google Scholar, N. H. Immunol. PubMed Scopus Google also a role in the of different chemerin These carboxyl-terminal or residues and by the from chemerin, an for the endogenous ascites reported by (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar). and the carboxyl-terminal from C5a and C3a, in this forms that are inactive Immunol. PubMed Scopus Google Scholar). Thus these are activated by serine proteases and by further protease A serine proteolytic may also regulate chemerin activity in with or enzymes in the processing of different active forms and in the of the attractant. the serum from we isolated chemerin was generated from blood and blood cells and leukocytes, is that chemerin was to proteases with the of the in vivo as proteases, or proteases released may have to chemerin may the between the and the serum proteolytic processing also the activities of many of the to the of serine protease cleavage of chemerin, cleavage results in or example, cleavage by the protease a P. S. D. C. A. E. I. J. FEBS Lett. 1998; PubMed Scopus Google Scholar). cleavage of activity to cells M. G. M. R. E. J. Exp. Med. PubMed Scopus Google Scholar). A cleavage of a I. PubMed Scopus Google Scholar). of protein by cathepsin a potent neutrophil chemoattractant that through M. A. J. PubMed Scopus Google Scholar). Thus the processing of a critical for the recruitment of In previous we found that CMKLR1 is expressed by circulating pDCs in human blood and that this pDCs from the major of dendritic a for trafficking (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar). pDCs are cells that can as or antigen-presenting cells. The effector of pDCs on the recruitment to a tissue receptor or viral pDCs into cells that also and process pDCs CMKLR1 (5Zabel B.A. Silverio A.M. Butcher E.C. J. Immunol. 2005; 174: 244-251Crossref PubMed Scopus (207) Google Scholar) and to G. Sozzani S. J. Immunol. 2001; PubMed Scopus Google Scholar, G. N. A. A. A.L. P. J. 2003; PubMed Scopus Google migration to and to T cells. the pDCs by in the of receptor into pDCs, of T cells M. Liu Y.J. J. Exp. Med. PubMed Scopus Google Scholar). to immune responses tissue or sterile is may of the of these and in this rapid in response to coagulation or fibrinolytic activation of chemerin a to of tissue injury. cells can CMKLR1 as well. example, (3Wittamer V. Franssen J.D. Vulcano M. Mirjolet J.F. Le Poul E. Migeotte I. Brezillon S. Tyldesley R. Blanpain C. Detheux M. Mantovani A. Sozzani S. Vassart G. Parmentier M. Communi D. J. Exp. Med. 2003; 198: 977-985Crossref PubMed Scopus (677) Google Scholar) that monocyte-derived macrophages can CMKLR1 in In we have found cells of the macrophage can also the receptor and to tissue macrophages in human ascites CMKLR1 as a that the for for chemerin in phagocytes and immune cells to sites of protease tissue macrophages similar to pDCs, of immune responses capable of potent or cells to a S. Nat. Immunol. 2003; PubMed Scopus Google Scholar). is to that the primary role of chemerin is to is a vascular or to the role of the and tissue is to a of or by and to rapidly the or In we have that several serine proteases of the and cascades activate the chemerin, a for rapid recruitment of CMKLR1-positive cells to sites of tissue or cell injury the of an and host response to injury infection on an network of serine proteases and a for recruitment of specialized and pDCs and CMKLR1-positive macrophages. We A. for and with the chemerin from serum and and J. for
35
De Yang, Qian Chen, Albert P. Schmidt et al. · The Journal of Experimental Medicine · 2000 · 1.2K citations · Full text
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
G. Angus McQuibban, Jiang-Hong Gong, Eric M. Tam et al. · Science · 2000 · 773 citations